COPD Drug May Be Harmful

Brent Adams

Attorney
(866) 735-1102 Ext 645

0 CommentsPrint ArticleSubscribe

According to a statement made on Tuesday, March 18 by the U.S. Food and Drug Administration (FDA), a drug used for the treatment of chronic obstructive pulmonary disease (COPD) may be harmful to those who use it. As if the disabling condition of COPD was not difficult enough, the FDA says that Spiriva, a lung drug manufactured by Pfizer Inc. and German-based Boehringer Ingelheim Pharmaceutical Inc., may carry with it an increased risk of stroke.
According to the FDA, there is no conclusive proof of the increased stroke risk, but they still wish to inform doctors and patients of potential problems as soon as possible.
Spiriva HandiHaler is a drug used for the treatment of COPD that has been co-promoted across the world by Pfizer and Boehringer Ingelheim.